and recommendation
Bellicum Pharmaceuticals, Inc. (BLCM)
Bellicum Pharmaceuticals is a clinical stage biopharmaceutical company focused on discovering and developing novel cellular immunotherapies for various forms of cancer, including both hematological and solid tumors, as well as orphan inherited blood disorders.
BLCM has three product candidates in clinical development: BPX-501, an adjunct T-cell therapy product candidate being evaluated in Phase I/II clinical trials in children and adults following a T-depleted, haploidentical hematopoietic stem cell transplant (HSCT); BPX-601, a GoCAR-T product candidate in Phase I development for solid tumors expressing the prostate stem cell antigen; and BPX-701, a T cell receptors (TCR) product candidate in Phase I development for AML with future development potential for treatment of solid tumors expressing the preferentially-expressed antigen in melanoma.
BLCM has collaboration agreements with Adaptimmune Therapeutics plc to evaluate, develop, and commercialize T-cell therapies; Ospedale Pediatrico Bambino Gesú for the design and development of various T cell immunotherapies; and Academisch Ziekenhuis Leiden for research to discover and validate high-affinity TCR product candidates targeting various cancer-associated antigens.
Bellicum Pharmaceuticals, Inc. was founded in 2004 and is headquartered in Houston, Texas.
- April 2, 2024 - 3:16pm | Out and About, Research Notes, Out and About, Earnings, Earnings Q3
- August 16, 2022 - 11:38am | Out and About, Research Notes, Out and About
- September 23, 2021 - 7:10pm | Out and About, Research Notes, Out and About, Earnings Q2
- January 28, 2021 - 6:22pm | Out and About, Research Notes, Out and About
- November 4, 2020 - 8:21am | Out and About, Research Notes, Out and About, Financings
- May 30, 2020 - 9:44am | Out and About, Research Notes, Out and About, Earnings Q1
- April 11, 2020 - 1:23pm | Out and About, Research Notes, Out and About, Earnings, Earnings Q4
- November 3, 2019 - 2:45pm | Out and About, Research Notes, Out and About, Earnings
- August 19, 2019 - 10:42am | Out and About, Out and About, Financings
- January 29, 2019 - 12:50pm | Out and About, Out and About
- November 7, 2018 - 6:52am | Out and About, Research Notes, Out and About, Earnings
- September 11, 2018 - 1:18pm | Out and About, Research Notes, Out and About, Earnings, Earnings Q2
- June 2, 2018 - 7:11am | Out and About, Out and About, Earnings, Earnings Q1
- April 16, 2018 - 7:43pm | Financings
- March 10, 2018 - 9:22am | Earnings, Earnings Q4
- March 4, 2018 - 11:11am | Analysis, Out and About
- January 30, 2018 - 7:59pm | Out and About, Research Notes
- November 3, 2017 - 1:08pm | Earnings, Earnings Q3
- May 5, 2017 - 8:59am | Earnings, Earnings Q1
- March 22, 2017 - 4:43pm | Research Notes, Financings